HighMark Wealth Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.19K | Sell |
74
-5
| -6% | -$350 | ﹤0.01% | 389 |
|
|
2025
Q1 | $5.82K | Hold |
79
| – | – | ﹤0.01% | 354 |
|
|
2024
Q4 | $5.16K | Hold |
79
| – | – | ﹤0.01% | 376 |
|
|
2024
Q3 | $6.14K | Sell |
79
-14
| -15% | -$1.09K | ﹤0.01% | 380 |
|
|
2024
Q2 | $7.22K | Buy |
93
+5
| +6% | +$388 | ﹤0.01% | 337 |
|
|
2024
Q1 | $5.93K | Buy |
88
+1
| +1% | +$67 | ﹤0.01% | 355 |
|
|
2023
Q4 | $5.86K | Hold |
87
| – | – | ﹤0.01% | 344 |
|
|
2023
Q3 | $5.89K | Hold |
87
| – | – | ﹤0.01% | 329 |
|
|
2023
Q2 | $6.2K | Hold |
87
| – | – | ﹤0.01% | 324 |
|
|
2023
Q1 | $6.02K | Buy |
87
+35
| +67% | +$2.42K | ﹤0.01% | 367 |
|
|
2022
Q4 | $3.53K | Hold |
52
| – | – | ﹤0.01% | 383 |
|
|
2022
Q3 | $3K | Buy |
+52
| New | +$3K | ﹤0.01% | 384 |
|